Show simple item record

 
dc.contributorDepartament de Salut
dc.date.accessioned2022-06-01T11:09:40Z
dc.date.available2022-06-01T11:09:40Z
dc.date.issued2022-03
dc.identifier.citationNous medicaments biològics en la profilaxi de la migranya. Butll Farmacovigil Cat. 2022;20(2):1-7.
dc.identifier.urihttp://hdl.handle.net/11351/7611
dc.descriptionPharmacology; Biological drugs; Migraine prophylaxis
dc.language.isocat
dc.language.isospa
dc.publisherDepartament de Salut
dc.relation.ispartofseriesButlletí de Farmacovigilància de Catalunya;20(2)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectMigranya - Tractament
dc.subjectAnticossos monoclonals
dc.subject.meshMigraine Disorders
dc.subject.meshAntibodies, Monoclonal
dc.titleNous medicaments biològics en la profilaxi de la migranya
dc.title.alternativeNuevos medicamentos biológicos en la profilaxis de la migraña
dc.typeinfo:eu-repo/semantics/article
dc.subject.decstrastornos migrañosos
dc.subject.decsanticuerpos monoclonales
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record